Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PARASTOP – Paracetamol with Strong Opioids
2024-515012-53-00Phase 3Completed
- Sponsor
- Oslo University Hospital
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in cancer pain, Non-hematologic malignancy, lymphosarcoma and 1 more comparing Paracetamol + strong opioid with Placebo + strong opioid (2 arms). Primary endpoint: Average pain intensity. Started Oct 2024; status: completed.
02
Drugs
Panamol
03
Conditions
cancer painNon-hematologic malignancylymphosarcomamultiple myeloma (MM)
Beyond the preview
Go deeper on 2024-515012-53-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-515012-53-00.